Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in…
5. $OSCR (Oscar Health Inc). Sentiment on X: 88% bullish, 12% bearish.
The @InvestLikeBest interview with $OSCR lives rent free in my head. Plus those $OSCR numbers look pretty freaking good. Thinking of taking a starter (even after the run). What am I missing?
$OSCR CRUSHED THEIR Q3 EARNINGS • Revenue $5.1B vs Est. $4.7B • EPS $0.49 vs Est. ($0.21) • MLR: 79.2% FY26 Guidance • Revenue $19.2B vs Est. $18.7B • Earnings From Operations: $900M • MLR: 81% https://t.co/JbkyGxvlpR
$OSCR crushed it again @mtbert says Oscar is on track for its strongest financial year, and sees disciplined pricing, products and technology supporting market-share growth and margin expansion in 2027. https://t.co/2lIFvKi7Mz
OSCAR HEALTH $OSCR JUST REPORTED Q3 EARNINGS - Revenue: $5.14B, beating expectations of $4.72B ? - EPS: $0.49, beating expectations of -$0.21 ? - Medical Loss Ratio: 84.0% (-450 bps YoY) - Adjusted EBITDA: $206.9M FY26 Guidance: - Revenue: $19.0B-$19.3B, above expectations of…
@801010athlete $OSCR has earnings tomorrow. However, Dems winning the midterms improves prospects for ACA subsidies. $RYAN is another name that could benefit. Less momentum for limits on lawsuit payouts could support demand for liability insurance.
11 analysts rate OSCR Hold on consensus.
Consensus price target: $36.40 (-0.79% downside from $36.69)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Blackley Richard Scott Chief Financial Officer | Aug 18, 2026 | Sale | 18,750 | $595.13K |
| Bertolini Mark T director, Chief Executive Officer | Jun 30, 2026 | Sale | 488,654 | $13.85M |
| Bertolini Mark T director, Chief Executive Officer | Jun 30, 2026 | Sale | 135,590 | $3.93M |
| Bertolini Mark T director, Chief Executive Officer | Jun 29, 2026 | Sale | 58,926 | $1.77M |
| Bertolini Mark T director, Chief Executive Officer | Jun 29, 2026 | Sale | 555,826 | $16.21M |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $11.7B | +27.5% | $-443.15M |
| 2024 | $9.18B | +56.54% | $25.43M |
| 2023 | $5.86B | +42.11% | $-270.73M |
Stock data for OSCR: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics